IL271456B - Pharmaceutical composition comprising pcsk9 inhibitor for use in treating hyperlipidemia - Google Patents

Pharmaceutical composition comprising pcsk9 inhibitor for use in treating hyperlipidemia

Info

Publication number
IL271456B
IL271456B IL271456A IL27145619A IL271456B IL 271456 B IL271456 B IL 271456B IL 271456 A IL271456 A IL 271456A IL 27145619 A IL27145619 A IL 27145619A IL 271456 B IL271456 B IL 271456B
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
pcsk9 inhibitor
treating hyperlipidemia
hyperlipidemia
pcsk9
Prior art date
Application number
IL271456A
Other languages
Hebrew (he)
Other versions
IL271456A (en
Original Assignee
Regeneron Pharma
Sanofi Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2014/060109 external-priority patent/WO2015054619A2/en
Application filed by Regeneron Pharma, Sanofi Biotechnology filed Critical Regeneron Pharma
Publication of IL271456A publication Critical patent/IL271456A/en
Publication of IL271456B publication Critical patent/IL271456B/en

Links

IL271456A 2013-10-11 2019-12-16 Pharmaceutical composition comprising pcsk9 inhibitor for use in treating hyperlipidemia IL271456B (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201361890154P 2013-10-11 2013-10-11
US201461923103P 2014-01-02 2014-01-02
US201461955514P 2014-03-19 2014-03-19
US201462004620P 2014-05-29 2014-05-29
US201462025104P 2014-07-16 2014-07-16
EP14306221 2014-07-31
US201462054571P 2014-09-24 2014-09-24
EP14306584 2014-10-09
PCT/US2014/060109 WO2015054619A2 (en) 2013-10-11 2014-10-10 Use of a pcsk9 inhibitor to treat hyperlipidemia

Publications (2)

Publication Number Publication Date
IL271456A IL271456A (en) 2020-01-30
IL271456B true IL271456B (en) 2021-08-31

Family

ID=68918439

Family Applications (1)

Application Number Title Priority Date Filing Date
IL271456A IL271456B (en) 2013-10-11 2019-12-16 Pharmaceutical composition comprising pcsk9 inhibitor for use in treating hyperlipidemia

Country Status (4)

Country Link
ES (1) ES2779126T3 (en)
IL (1) IL271456B (en)
PT (1) PT3055333T (en)
TW (1) TWI723478B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114525258A (en) * 2020-10-30 2022-05-24 未来智人再生医学研究院(广州)有限公司 Pluripotent stem cell expressing PCSK9 blocker or derivative thereof and application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130064834A1 (en) * 2008-12-15 2013-03-14 Regeneron Pharmaceuticals, Inc. Methods for treating hypercholesterolemia using antibodies to pcsk9
MX367075B (en) * 2011-01-28 2019-08-05 Sanofi Biotechnology Human antibodies to pcsk9 for use in methods of treating particular groups of subjects.
JOP20200043A1 (en) * 2011-05-10 2017-06-16 Amgen Inc Methods of treating or preventing cholesterol related disorders

Also Published As

Publication number Publication date
TWI723478B (en) 2021-04-01
PT3055333T (en) 2020-03-11
IL271456A (en) 2020-01-30
TW202021615A (en) 2020-06-16
ES2779126T3 (en) 2020-08-13

Similar Documents

Publication Publication Date Title
IL244995B (en) Pharmaceutical composition comprising pcsk9 inhibitor for use in treating hyperlipidemia
HRP20171474T1 (en) Triazolopyrazines as brd4 inhibitors for use in the treatment of cancer
HK1215378A1 (en) Pharmaceutical composition, methods for treating and uses thereof
EP2950884A4 (en) Compositions and methods for treating surface wounds
SI3086781T1 (en) Pharmaceutical composition of dpp-iv inhibitor in combination with metformin
HK1224184A1 (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
EP2990057A4 (en) Novel use for pai-1 inhibitor
IL240553A0 (en) Il-1ß inhibitor composition and use thereof
IL242584B (en) Immunogenic composition for use in therapy
IL278109B (en) A composition comprising phenoxypropylamine compounds for use in treating or improving sleep disorder
PL3060224T3 (en) Plant-based composition for use in the treatment of cough
EP3020399A4 (en) Novel pharmaceutical composition for preventing or treating cancer
IL271456B (en) Pharmaceutical composition comprising pcsk9 inhibitor for use in treating hyperlipidemia
HK1219893A1 (en) Compound and methods for treating long qt syndrome qt
ZA201507015B (en) Composition for treating hemorrhoids
LT2863931T (en) Compositions for use in treating wounds
LT2863932T (en) Composition for use in the treatment of lymphedema
ZA201408732B (en) Composition and methods for treating wounds
ZA201508585B (en) Immunogenic composition for use in therapy
IL239872A0 (en) Matriptase inhibitors and pharmaceutical compositions containing them
GB201314623D0 (en) Novel mucinase for use in therapy or prophylaxis
SG11201507720PA (en) Anti-tumoral composition comprising a pi3kbeta-selective inhibitor and a pi3kalpha-selective inhibitor
GB201304675D0 (en) Novel compositions having use in therapy